This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (422) Complementary and Alternative Medicine (109) Pharmacology and Pharmaceutics (120) Methods and Feasibility Studies (481)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/79579, first published .
Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Authors of this article:

Shoujiang Hao1 Author Orcid Image ;   Xiaoli Li2 Author Orcid Image ;   Shulan Hao2 ;   Xiaoying Zhang2 ;   Xiaojun Qi1 ;   Gang Jin3 ;   Fangfang Shen4 ;   Likun Liu2 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.